April 22, 2026 Overcoming Resistance and RevMed’s Next Drug: RM-055 as a Catalytic Inhibitor in the RAS Inhibitor Arms Race
April 22, 2026 Sweden Recommends Low-Dose Aspirin for Specific Patients Starting January 2026, Based on Research Showing Cancer Cell Suppression via Immune Cell Activation in Animal Studies
April 22, 2026 Overlooked Breast Cancer Subtypes Face Critical Funding Gaps as Patients Demand Action
